HEMISPHERX BIOPHARMA INC (HEB)

Overview Price 0.34 Price Change Today 0.00 (0.00%) P&P rating Zacks Rank N/A - N/A Open Price $0.00 Previous Close $0.34 Daily Range $0.00 - $0.00 52-Week Range $0.17 - $0.57 Volume 0 Hemispherx Biopharma, Inc. is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx's flagship products include Alferon N Injection and the experimental therapeutics Ampligen and Oragens. Alferon N Injection is approved for a category of STD infection, and Ampligen and Oragens represent a large portfolio experimental RNA nucleic acids being developed for globally important viral diseases, severely debilitating disorders and biodefense applications. Hemispherx's platform technology includes large and small agent components for potential treatment of various severely debilitating and life threatening diseases. The Company is actively engaged in further expansion of its intellectual property on a world wide basis to reflect the global distribution of the various disorders which its platform technologies address. Other Resources for HEB Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary No Commentary Found for This Ticker. Hemispherx Biopharma, Inc. is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx's flagship products include Alferon N Injection and the experimental therapeutics Ampligen and Oragens. Alferon N Injection is approved for a category of STD infection, and Ampligen and Oragens represent a large portfolio experimental RNA nucleic acids being developed for globally important viral diseases, severely debilitating disorders and biodefense applications. Hemispherx's platform technology includes large and small agent components for potential treatment of various severely debilitating and life threatening diseases. The Company is actively engaged in further expansion of its intellectual property on a world wide basis to reflect the global distribution of the various disorders which its platform technologies address.   No brokerage coverage for HEB   HEB Ratings: BUY  SELL  HOLD HEB Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 28 Buy 0 Sell   Top Buy Analysis BUY: HEB Company: HEMISPHERX BIOPHARMA INC Points: -118.00 Start Price: $1.90 Start Date: 08/19/2009 7:36 PM FedeTech P&P Score: 99.46 Recs: high risk - high reward Comments: 0 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
stocklook	4.04	12/04/09	Three Penny Stocks to Avoid (HEB) (CIT) (IRLD)	0
Zacks_Analysts	0.00	11/23/11	Mediocre 4Q for H-P - Analyst Blog	0
Zacks_Analysts	0.00	08/19/11	HP Reports In Line - Analyst Blog	0
Zacks_Analysts	0.00	02/23/11	Encouraging Quarter for HP - Analyst Blog	0
Zacks_Analysts	0.00	11/23/10	H-P Beats EPS Estimates (revised) - Analyst Blog	0
Zacks_Analysts	0.00	11/23/10	HP Beats EPS, Misses Rev - Analyst Blog	0
Zacks_Analysts	0.00	08/23/10	Hewlett-Packard Performs Well - Analyst Blog	0
Zacks_Analysts	0.00	05/19/10	Hewlett-Packard Beats - Analyst Blog	0
Zacks_Analysts	0.00	02/18/10	Hewlett-Packard Delivers - Analyst Blog	0

Pages: [ 1 ]  2  >>

Commentary

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $1.90 Points: -118.00 Created: 08/19/2009 high risk - high reward Comments: 0 | Comment FedeTech Recs:

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $1.94 Points: -134.07 Created: 06/22/2009 95% approval Comments: 0 | Comment phongdinh Recs:

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $1.59 Points: -127.97 Created: 05/28/2009 Bet on upcoming FDA drug approval Comments: 0 | Comment gdrumm05 Recs:

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $1.69 Points: -131.51 Created: 05/27/2009 could this be the next microsoft of bio? Comments: 0 | Comment 24Chips Recs:

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $3.43 Points: -82.30 Created: 01/01/2008 Comments: 0 | Comment sneakyfrenchie Recs:

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $4.04 Points: -83.78 Created: 01/01/2008 Comments: 0 | Comment Zippy Recs:

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $2.27 Points: -77.31 Created: 01/01/2008 Comments: 0 | Comment metical1 Recs:

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $2.99 Points: -80.86 Created: 01/01/2008 Comments: 0 | Comment sidewinderdave Recs:

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $2.87 Points: -80.40 Created: 01/01/2008 Comments: 0 | Comment rockport Recs:

BUY: HEMISPHERX BIOPHARMA INC (HEB) Start Price: $3.44 Points: -82.33 Created: 01/01/2008 Comments: 0 | Comment GOD Recs:

Pages: [ 1 ]  2   3  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
FedeTech	99.46	BUY	One to Three Months	08/19/2009	$1.90	$0.34 (-1.38%)	-82.35%	+35.65%	-118.00	view close
phongdinh		BUY	Week or Less	06/22/2009	$1.94	$0.34 (-1.38%)	-82.72%	+51.36%	-134.07	view close
gdrumm05	2.30	BUY	Week to a Month	05/28/2009	$1.59	$0.34 (-1.38%)	-78.91%	+49.06%	-127.97	view close
24Chips	98.84	BUY	Week or Less	05/27/2009	$1.69	$0.34 (-1.38%)	-80.16%	+51.35%	-131.51	view close
sneakyfrenchie	27.37	BUY	Six Months to a Year	01/01/2008	$3.43	$0.34 (-1.38%)	-90.22%	-7.92%	-82.30
Zippy	16.25	BUY	Six Months to a Year	01/01/2008	$4.04	$0.34 (-1.38%)	-91.70%	-7.92%	-83.78
metical1		BUY	Six Months to a Year	01/01/2008	$2.27	$0.34 (-1.38%)	-85.23%	-7.92%	-77.31
sidewinderdave	43.51	BUY	Six Months to a Year	01/01/2008	$2.99	$0.34 (-1.38%)	-88.79%	-7.92%	-80.86
rockport	33.50	BUY	Six Months to a Year	01/01/2008	$2.87	$0.34 (-1.38%)	-88.32%	-7.92%	-80.40
GOD		BUY	Six Months to a Year	01/01/2008	$3.44	$0.34 (-1.38%)	-90.25%	-7.92%	-82.33

Pages: [ 1 ]  2   3  >>